Home Crystal structure of 3-[methyl(phenyl)amino]-1-phenylthiourea, C14H15N3S
Article Open Access

Crystal structure of 3-[methyl(phenyl)amino]-1-phenylthiourea, C14H15N3S

  • Chien Ing Yeo and Edward R.T. Tiekink ORCID logo EMAIL logo
Published/Copyright: July 9, 2019

Abstract

C14H15N3S, monoclinic, P21/c (no. 14), a = 10.4801(1) Å, b = 10.8132(1) Å, c = 12.1341(1) Å, β = 107.823(1)°, V = 1309.08(2) Å3, Z = 4, Rgt(F) = 0.0266, wRref(F2) = 0.0728, T = 100(2) K.

CCDC no.: 1912669

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.18 × 0.09 × 0.05 mm
Wavelength:Cu Kα radiation (1.54184 Å)
μ:2.07 mm−1
Diffractometer, scan mode:XtaLAB Synergy, ω
θmax, completeness:67.1°, >99%
N(hkl)measured, N(hkl)unique, Rint:16316, 2338, 0.025
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2266
N(param)refined:170
Programs:CrysAlisPRO [1], SHELX [2], [3], WinGX/ORTEP [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
S10.34126(3)0.36235(3)0.50973(2)0.02291(11)
N10.27734(9)0.28022(9)0.28687(8)0.0174(2)
H1N0.2881(14)0.2973(13)0.2205(9)0.021*
N20.41261(10)0.44811(9)0.33649(8)0.0197(2)
H2N0.4662(12)0.4958(12)0.3887(10)0.024*
N30.41405(10)0.45604(9)0.22106(8)0.0175(2)
C10.34249(11)0.35979(10)0.37083(10)0.0172(2)
C20.19660(11)0.17545(11)0.28940(10)0.0166(2)
C30.20148(12)0.10995(11)0.38922(10)0.0204(3)
H30.25850.13670.46230.024*
C40.12241(12)0.00505(11)0.38144(11)0.0223(3)
H40.1246−0.03880.44980.027*
C50.04058(12)−0.03621(11)0.27532(11)0.0221(3)
H5−0.0124−0.10840.27070.027*
C60.03667(12)0.02894(11)0.17573(11)0.0221(3)
H6−0.01890.00080.10260.027*
C70.11320(12)0.13459(11)0.18224(10)0.0195(3)
H70.10900.17930.11390.023*
C80.35658(11)0.56884(10)0.16702(9)0.0170(2)
C90.24293(12)0.61596(11)0.18976(11)0.0223(3)
H90.20970.57700.24560.027*
C100.17873(12)0.71932(12)0.13098(12)0.0270(3)
H100.10120.75040.14650.032*
C110.22629(13)0.77820(12)0.04964(11)0.0268(3)
H110.18140.84870.00920.032*
C120.33986(12)0.73283(11)0.02827(10)0.0225(3)
H120.37320.7728−0.02710.027*
C130.40599(12)0.62918(11)0.08701(10)0.0182(3)
H130.48470.59960.07250.022*
C140.54288(12)0.41597(11)0.20906(10)0.0216(3)
H14A0.56770.33580.24740.032*
H14B0.61200.47720.24500.032*
H14C0.53500.40810.12680.032*

Source of material

Phenyl isothiocyanate (Merck; 1.19 mL, 0.01 mol) in ethanol (10 mL) was added dropwise to an equivalent molar amount of 1-methyl-1-phenylhydrazine (Merck; 1.18 mL, 0.01 mol) in ethanol (10 mL). The resulting mixture was stirred for 2 h and left for evaporation at room temperature, yielding colourless crystals after 2 weeks. M.pt. (Biobase automatic melting point apparatus MP450): 426–427 K. Elem. Anal. (Leco TruSpec Micro CHN Elemental Analyser): Calc. for C14H15N3S: C, 65.34; H, 5.87; N, 16.33%. Found: C, 65.14; H, 5.76; N, 15.95%. 1H NMR (Bruker Ascend 400 MHz NMR spectrometer with chemical shifts relative to tetramethylsilane; CDCl3): δ [p.p.m.] 8.87 (s, br, 1H, Ph—NH), 7.67 (s, br, 1H, N—NH), 7.58 (d, 2H, N(H)C6H5-2,6, 3JHH = 7.72 Hz), 7.35 (t, 4H, NC6H5-3,5 and N(H)C6H5-3,5, 3JHH = 7.86 Hz), 7.20 (t, 1H, N(H)C6H5-4, 3JHH = 7.42 Hz), 7.06–7.01 (m, 3H, NC6H5-2,4,6), 3.21 (s, 3H, NCH3). 13C{1H} NMR (Bruker Ascend 400 MHz NMR spectrometer; CDCl3): δ [p.p.m.] 180.0 (Cq), 148.8 (NC6H5, C1), 137.6 (N(H)C6H5, C1), 129.6 (N(H)C6H5, C3, C5), 128.7 (N(H)C6H5, C2, C6), 126.1 (N(H)C6H5, C4), 124.3 (NC6H5, C3, C5), 122.5 (NC6H5, C4), 114.9 (NC6H5, C2, C6), 41.9 (NCH3). IR (Bruker Vertex 70v FTIR spectrophotometer, cm−1): 3265 (m) ν(N—H), 1485 (vs) ν(C—N), 1255 (vs) ν(C=S).

Experimental details

The C-bound H atoms were geometrically placed (C—H = 0.95–0.98 Å) and refined as riding with Uiso(H) = 1.2–1.5Ueq(C). The N-bound H-atoms were located in a difference Fourier map but were refined with a distance restraint of N—H = 0.88±0.01 Å, and with Uiso(H) set to 1.2Uequiv(N).

Comment

With the possibility of up to four substitutions, thiourea derivatives, i.e. molecules of the general formula R1(R2)NC(=S)N(R3)R4 for R1–4 = alkyl/aryl, comprise a rich diversity of chemical species [5]. The primary interest in these molecules relate to their use as dual hydrogen bonding catalysis for asymmetric synthesis [6] and for their utility as potential pharmaceutical agents [7]. In continuation of recent studies in this area [8], herein the crystal and molecular structures of the title compound, PhN(Me)N(H)C(=S)N(H)Ph, are described.

The molecule is shown in the figure (70% displacement ellipsoids) and comprises a strictly planar core with the r.m.s. deviation of the C1, N1, N2 and S1 atoms being 0.0059 Å, and with the appended N3 [0.0538(16) Å] and C2 [0.0284(19) Å] atoms lying to either side of the least-squares plane. The dihedral angles between the central plane and the N1- and N3-bound phenyl rings are 21.40(6) and 83.43(3)°, respectively, showing the overall molecule to be twisted; the dihedral angle between the phenyl rings is 83.99(4)°. The amine-H atoms lie to opposite sides of the central plane which allows for the formation of an intramolecular amine-N1—H1n⋯N3(amine) hydrogen bond [H1n⋯N3 = 2.164(14) Å, N1⋯N3 = 2.6467(14) Å with angle at H1n = 114.8(10)°] which closes an S(5) loop.

In the crystal, centrosymmetrically related molecules are connected by amine-N2—H⋯⋅S1(thione) hydrogen bonds [N2—H2n⋯S1i: H2n⋯S1i = 2.534(13) Å, N2⋯S1i = 3.3749(10) Å with angle at H2n = 161.5(11)° for symmetry operation 1 – x, 1 – y, 1 – z]. This mode of association results in the formation of eight-membered {⋯HNCS}2 synthons. The dimeric aggregates are connected into a three-dimensional architecture by phenyl- and methyl-C—π(phenyl) interactions whereby the C8—C13 phenyl ring accepts both contacts. [C4—H4⋯Cg(C8—C13)ii = 2.62 Å with angle at H4 = 139° and C14—H14a⋯Cg(C8—C13)iii = 2.59 Å with angle at H14a = 159° for symmetry operations ii: x, 1/2 – y, 1/2 + z and iii: 1 – x, −1/2 + y, 1/2 – z].

The conformation of the molecule and the formation of {⋯HNCS}2 synthons in the molecular packing of the title compound is found in each of the closely related literature precedents PhN(Me)N(H)C(=S)N(H)(PhMe-4) [8], Me2NN(H)C(=S)N(H)Ph [9], PhN(Me)N(H)C(=S)N(H)(PhCl-4) [10], (PhCN-4)N(H)N(H)C(=S)N(H)Ph [11] and (PhNO2-4)N(H)N(H)C(=S)N(H)Ph [11].

Acknowledgements

The Research Centre for Crystalline Materials (Sunway University) is thanked for providing the X-ray data.

References

1. Agilent Technologies: CrysAlis PRO. Agilent Technologies, Santa Clara, CA, USA (2017).Search in Google Scholar

2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

3. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central

4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar

5. Saeed, A.; Flörke, U.; Erben, M. F.: A review on the chemistry, coordination, structure and biological properties of 1-(acyl/aroyl)-3-(substituted) thioureas. J. Sulfur Chem. 35 (2014) 318–355.10.1080/17415993.2013.834904Search in Google Scholar

6. Nishikawa, Y.: Recent topics in dual hydrogen bonding catalysis. Tetrahedron Lett. 59 (2018) 216–223.10.1016/j.tetlet.2017.12.037Search in Google Scholar

7. Kožurková, M.; Sabolová, D.; Kristian, P.: A review on acridinylthioureas and its derivatives: biological and cytotoxic activity. J. Appl. Toxicol. 37 (2017) 1132–1139.10.1002/jat.3464Search in Google Scholar PubMed

8. Yeo, C. I.; Tiekink, E. R. T.: 1-[N—Methyl—N—(phenyl)amino]-3-(4-methylphenyl)thiourea. Molbank 2019 (2019) M1052 (5 pages).10.3390/M1052Search in Google Scholar

9. López-Torres, E.; Dilworth, J. R.: Reactivity of thiosemicarbazides with redox active metal ions: controlled formation of coordination complexes versus heterocyclic compounds. Chem. Eur. J. 15 (2009) 3012–3023.10.1002/chem.200801446Search in Google Scholar PubMed

10. Yeo, C. I.; Tiekink, E. R. T.: Crystal structure of 1-(4-chlorophenyl)-3-[methyl(phenyl)amino]thiourea, C14H14ClN3S. Z. Kristallogr. NCS 234 (2019) 989–990.10.1515/ncrs-2019-0205Search in Google Scholar

11. Li, Z.; Wu, F.-Y.; Guo, L.; Li, A.-F.; Jiang, Y.-B.: Enhanced anion binding of N-(anilino)thioureas. contribution of the N-anilino -NH proton acidity. J. Phys. Chem. B 112 (2008) 7071–7079.10.1021/jp801531wSearch in Google Scholar PubMed

Received: 2019-03-19
Accepted: 2019-04-28
Published Online: 2019-07-09
Published in Print: 2019-09-25

©2019 Chien Ing Yeo et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of poly[diaqua-(μ8-1,1′:2′,1′′-terphenyl-3,3′′,4′,5′-tetracarboxylato-κ8O1:O2:O3:O4:O5:O6:O7:O8)dicopper(II)], C22H14Cu2O10
  3. Crystal structure of 2-((1H-benzo[d]imidazol-2-ylimino)methyl)-4,6-di-tert-butylphenol, C22H27N3O
  4. Crystal structure of (4-ethoxynaphthalen-1-yl)(furan-2-yl)methanone, C17H14O3
  5. Crystal structure of 1-nonylpyridazin-1-ium iodide, C13H23N2I
  6. Crystal structure of bis[diaqua(1,10-phenanthroline-κ2N, N′)-copper(II)]diphenylphosphopentamolybdate dihydrate, C36H38Cu2Mo5N4O27P2
  7. The crystal structure of tetrakis(imidazole)-copper(I) hexafluorophosphate, C12H16CuF6PN8
  8. The crystal structure of dimethyl ((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)phosphonate, C23H33O4P
  9. Crystal structure of diaqua-bis(1,10-phenanthroline κ2N,N′)nickel(II) trifluoroacetate- trifluoroacetic acid (1/1), C30H21F9N4NiO8
  10. Crystal structure of 2-(naphthalen-2-yl)-1,8-naphthyridine, C18H12N2
  11. Synthesis and crystal structure of a new polymorph of diisopropylammonium trichloroacetate, C8H16Cl3NO2
  12. Crystal structure of dimethanol-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)cadmium(II) C34H34CdN12O2S2
  13. Crystal structure of ethyl 2,2-difluoro-2-(7-methoxy-2-oxo-2H-chromen-3-yl)acetate, C14H12F2O5
  14. The crystal structure of bis[μ2-(N,N-diethylcarbamodithioato-κSSS′)] bis[1′-(diphenylphosphino-κP)-1-cyanoferrocene]disilver(I), C56H56Ag2Fe2N4P2S4
  15. Crystal structure of bis(di-n-butylammonium) tetrachloridodiphenylstannate(IV), C28H50Cl4N2Sn
  16. The crystal structure of poly[(μ5-2-((5-bromo-3-formyl-2-hydroxybenzylidene)amino)benzenesulfonato-κ6O:O:O,O′:O′:O′′)sodium(I)], C13H9O4NSBrNa
  17. Crystal structure of catena-{poly[bis(O,O′-diethyldithiophosphato-S)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)-zinc(II)] di-acetonitrile solvate}, {C20H30N4O4P2S4Zn ⋅ 2 C2H3N}n
  18. Halogen and hydrogen bonding in the layered crystal structure of 2-iodoanilinium triiodide, C6H7I4N
  19. Crystal structure of cyclohexane-1,4-diammonium 2-[(2-carboxylatophenyl)disulfanyl]benzoate — dimethylformamide — monohydrate (1/1/1), [C6H16N2][C14H8O4S2] ⋅ C3H7NO⋅H2O
  20. The synthesis and crystal structure of isobutyl 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C16H13Cl2F6N3O3S
  21. Isolation and crystal structure of bufotalinin — methanol (1/1), C25H34O7
  22. Crystal structure of benzylbis(1,3-diphenylpropane-1,3-dionato-κ2O,O′) chloridotin(IV), C37H29ClO4Sn
  23. Crystal structure of Bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imidazol)}diiodidocadmium(II), [Cd(C11H11N5)2I2], C22H22N10I2Cd
  24. Crystal structure of 4-isobutoxybenzaldehyde oxime, C11H15NO2
  25. The crystal structure of bis(acetato-κ1O)-bis(N′-hydroxypyrimidine-2-carboximidamide-κ2N,N′)manganese(II) — methanol (1/2), C14H18MnN8O6, 2(CH3OH)′
  26. Crystal structure of poly[bis(μ2-bis(4-(1H-imidazol-1-yl)phenyl)amine-κ2N:N′)-bis(nitrato-κO)cadmium(II)], C36H30CdN12O6
  27. Crystal structure and optical properties of 1,6-bis(methylthio)pyrene, C18H14S2
  28. The crystal structure of hexaquamagnesium(II) bis(3,4-dinitropyrazol-1-ide), C6H14MgN8O14
  29. Halogen bonds in the crystal structure of 4,3:5,4-terpyridine – 1,4-diiodotetrafluorobenzene (1/1), C21H11F4I2N3
  30. Crystal structure and photochromic properties of a novel photochromic perfluordiarylethene containing a triazole bridged pyridine group moiety, C24H18F6N4S2
  31. Crystal structure of bis[(μ3-oxido)-(μ2-(N,N-diisopropylthiocarbamoylthio) acetato-κ2O,O′)-((N,N-diisopropylthiocarbamoylthio)acetato-κO)-bis(di-4-methylbenzyl-tin(IV))], C100H136N4O10S8Sn4
  32. Crystal structure of dibromidobis(4-bromobenzyl)tin(IV), C14H12Br4Sn
  33. The crystal structure of (4Z)-2-[(E)-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)methyl]-4-[(1-ethyl-3,3-dimethyl-3H-indolium-2-yl)methylidene]-3-oxocyclobut-1-en-1-olate, C30H32N2O2
  34. The crystal structure of (E)-3-(4-(dimethylamino)styryl)-5,5-dimethylcyclohex-2-en-1-one, C18H23NO
  35. Crystal structure of dihydrazinium 1H-pyrazole-3,5-dicarboxylate, C5H12N6O4
  36. Crystal structure of poly[μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)-(μ2-4-sulfidobenzoate-κ2O:S)cobalt(II)] dihydrate, C42H44Co2N8O7S2
  37. Crystal structure of 8-(3,4-dimethylbenzylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione, C17H18O4
  38. Crystal structure of 4-(2-bromo-4-(6-morpholino-3-phenyl-3H-benzo[f]chromen-3-yl) cyclohexa-2,5-dien-1-yl)morpholine, C33H31BrN2O
  39. Synthesis and crystal structure of 2-((1-phenyl-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methylene)-2,3-dihydro-1H-inden-1-one, C23H16N2OS
  40. Crystal structure of poly[(μ2-1,1′-(oxybis(4,1-phenylene)bis(1H-imidazole)-κ2N,N′)(μ2-1,3-benzenecarboxylato-κ3O,O′:O′′)zinc(II)] dihydrate, C26H22N4O7Zn
  41. Crystal structure of diaqua-bis(cinnamato-κ2O,O′)zinc(II), C18H18ZnO6
  42. Crystal structure of 2-(prop-2-yn-1-yloxy)-1-naphthaldehyde, C14H10O2
  43. Crystal structure and photochromic properties of 1-(2-methyl-5-phenyl-3-thienyl)-2-{2-methyl-5-[4-(9-fluorenone hydrazone)-phenyl]-3-thienyl}perfluorocyclopentene, C41H26F6N2S2
  44. Hydrothermal synthesis and crystal structure of cylo[tetraaqua-bis(μ2-1,4-bis(1H-benzo[d]imidazol-1-yl)but-2-ene-κ2N:N′)-bis(μ2-4-nitro-phthalate-κ2O,O′)dinickel(II)], C26H23N5O8Ni
  45. Crystal structure of 3-[methyl(phenyl)amino]-1-phenylthiourea, C14H15N3S
  46. Crystal structure of 1-(4-chlorophenyl)-3-[methyl(phenyl)amino]thiourea, C14H14ClN3S
  47. Crystal structure of 2-tert-butyl-1H-imidazo[4,5-b]pyridine, C10H13N3
  48. Crystal structure of 5-carboxy-2-(2-carboxyphenyl)-1H-imidazol-3-ium-4-carboxylate dihydrate, C12H8N2O6⋅2(H2O)
  49. The crystal structure of dichlorido-μ2-dichlorido-(η2-1,4-bis(4-vinylbenzyl)-1,4-diazabicyclo[2.2.2]octane-1,4-diium)dicopper(I), C24H30N2Cu2Cl4
  50. Crystal structure of 4-bromobenzyl (Z)-N-(adamantan-1-yl)morpholine-4-carbothioimidate, C22H29BrN2OS
  51. Crystal structure of (4S,4aS,6aR,6bR,12aS,12bR,14aS,14bR)-3,3,6a,6b,9,9,12a-heptamethyloctadecahydro-1H,3H-4,14b-ethanophenanthro[1,2-h]isochromene-1(6bH)-one, C30H48O2
  52. Crystal structure of 3,5-bis(trifluoromethyl)benzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C30H33F6N3S
  53. The crystal structure of 3-methoxyphenanthridin-6(5H)-one, C14H11NO2
  54. Crystal structure of 4-(5,5-difluoro-1,3,7,9-tetramethyl-3H,5H-5λ4-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinin-10-yl)pyridin-1-ium tetraiodidoferrate(III), C18H19BF2FeI4N3
  55. Crystal structure of 2-(3-methoxyphenyl)-3-((phenylsulfonyl)methyl)imidazo[1,2-a]pyridine, C21H18N2O3S
  56. Crystal structure of [(2-(2-chlorophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κ2O,O′) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) perchlorate, C29H50Cl2N4NiO8
  57. Crystal structure of (Z)-6-(dimethylamino)-3,3-bis(4-(dimethylamino)phenyl)-2-(2-(quinoxalin-2-ylmethylene)hydrazinyl)-2,3-dihydroinden-1-one, C35H35N7O
  58. 5-Methyl-N′-[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbonyl]-1-(4-methylphenyl)-1H-1,2,3-triazole-4-carbohydrazide, C22H22N8O2
  59. Crystal structure of 2,3-dichloro-6-methoxyquinoxaline, C9H6Cl2N2O
  60. Synthesis and crystal structure of 7-chloro-2-(ethylsulfinyl)-6-fluoro-3-(1H-pyrazole-1-yl)-4H-thiochromen-4-one, C13H10FN3OS2
  61. Crystal structure of 4-ethylpiperazine-1-carbothioic dithioperoxyanhydride, C14H26N4S4
  62. Crystal structure of 2-(2-(6-methylpyridin-2-yl)naphthalen-1-yl)pyrimidine, C20H15N3
  63. The crystal structure of N′-((1E,2E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-ylidene)-3-methylbenzohydrazide, C23H22N2O4
  64. Crystal structure of catena-poly[(μ2-isophthalato-κ2O:O′)-(2,5-di(pyrazin-2-yl)-4,4′-bipyridine-κ3N,N′,N′′)zinc(II)] — water (2/5), C26H21N6O6.5Zn
  65. Crystal structure of (3E,5E)-3,5-bis(3-nitrobenzylidene)-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-one — dichloromethane (2/1), C53H38Cl2F6N6O14S2
  66. Crystal structure of (μ2-oxido)-bis(N,N′-o-phenylenebis(salicylideneiminato))diiron(III) — N,N′-dimethylformamide, C47H43Fe2N4O9
  67. Crystal structure of N1,N3-bis(2-hydroxyethyl)-N1, N1,N3,N3-tetramethylpropane-1,3-diaminium dibromide, C11H28Br2N2O2
  68. Crystal structure of (E)-N-(4-chlorophenyl)-1-(pyridin-2-yl)methanimine, C12H9ClN2
  69. Crystal structure of 8-bromo-6-oxo-2-phenyl-6H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, C18H11BrNO2
  70. Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride trihydrate, C8H18N8Cl2 ⋅ 3 H2O
  71. Crystal structure of (E)-4-bromo-N-(pyridin-2-ylmethylene)aniline, C12H9BrN2
  72. Crystal structure of bis[(2-(3-bromophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ-O)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Br2N4NiO8
  73. The crystal structure of (1E,2E)-2-methyl-4-((7-oxo-7H-furo[3,2-g]chromen-9-yl)oxy)but-2-enal O-isonicotinoyl oxime–trichloromethane (3/1), C67H49Cl3N6O18
  74. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium hexafluoridophosphate(V), C8H13F6N2O2P
  75. Crystal structure of bis[(2-(2-bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylato-κO)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II) hemihydrate C42H65Br2N4NiO8.5
  76. The crystal structure of N-(7-(4-fluorobenzylidene)-3-(4-fluorophenyl)-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbonothioyl)benzamide, C28H23F2N3OS
  77. The crystal structure of N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide, C18H20N4O2
  78. Crystal structure of (E)-2-(3,6-bis(ethylamino)-2,7-dimethyl-9H-xanthen-9-yl)-N′-((6-methylpyridin-2-yl)methylene)benzohydrazide – methanol (1/1), C34H37N5O3
  79. Crystal structure of 2-oxo-1-(pyrimidin-5-ylmethyl)-3-(3-(trifluoromethyl)phenyl)-1,2-dihydro-5l4-pyrido[1,2-a]pyrimidin-4-olate, C20H13F3N4O2
  80. Crystal structure of poly[(μ3-9H-carbazole-3,6-dicarboxylato-κ3O1: O2: O3)(μ2-4-(pyridin-4-yl)pyridine-κ2N1:N1′)zinc(II)], C19H11N2O4Zn
  81. Crystal structure of (E)-N′-((1,8-dihydropyren-1-yl)-methylene)picolinohydrazide, C23H15N3O
  82. Crystal structure of catena-poly{[μ2-1,2-bis(diphenylphosphino)ethane]dichloridocadmium(II)}, C26H24CdCl2P2
  83. Crystal structure of the 1:2 co-crystal between N,N′-bis(4-pyridylmethyl)oxalamide and acetic acid as a dihydrate, C14H14N4O2⋅2 C2H4O2⋅2 H2O
  84. Crystal structure of the co-crystal N,N′-bis(3-pyridylmethyl)oxalamide acetic acid (1/2), C14H14N4O2⋅2C2H4O2
  85. Crystal structure of the co-crystal N,N′-bis(4-pyridylmethyl)oxalamide and 2,3,5,6-tetrafluoro-1,4-di-iodobenzene (1/1), C14H14N4O2⋅C6F4I2
  86. Crystal structure of the co-crystal 4-[(4-carboxyphenyl)disulfanyl]benzoic acid–(1E,4E)-1-N,4-N-bis(pyridin-4-ylmethylidene)cyclohexane-1,4-diamine (1/1), C14H10O4S2⋅C18H20N4
  87. Crystal structure of hexacarbonyl-bis(μ2-di-n-propyldithiocarbamato-κ3S,S′:S3S:S:S′)-di-rhenium(I), C20H28N2O6Re2S4
  88. Crystal structure of fac-tricarbonyl-morpholine-κN-(morpholinocarbamodithioato-κ2S,S′)rhenium(I), C12H17N2O5ReS2
Downloaded on 21.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0204/html
Scroll to top button